Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

 

 

 

  

PD 184352 - CI-1040

 

 

CAS 212631-79-3

C17H14ClF2IN2O2  MW 478.67

Purity: 99%

Soluble in DMSO

 

 

 

 

Ordering Information:

 

Cat. No. Axon 1368    Prime Source

 

Qty1: 5 mg (research sample) / €125  $163

Promotion: 2 x 5 mg @ €160  $208

Qty2: 25 mg (research sample) / €375  $488

Promotion: 2 x 25 mg @ €560  $728

Qty3: on request

 

Send enquiry to: order@axonmedchem.com

or by fax to: +31-50-3600390.

 

Contact us for payment and tech support.

Biological Activity:

 

Potent, selective and non-competitive inhibitor of MEK 1 (also called MKK 1) and its activation; highly recommended tool to inhibit MKK1 or MKK1 plus MKK5.

 

References: online 1, 2, 3

 

RR Mattingly et al. The MEK inhibitor PD184352/CI-1040 selectively induces apoptosis in malignant schwannoma cell lines. J. Pharmacol. Exp. Ther. 2006, 316, 456-465.

 

D Liu et al. Inhibitory Effects of the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 on the Proliferation and Tumor Growth of Thyroid Cancer Cells with BRAF or RAS Mutations. J. Clin. Endocrinol. & Meta. 2007, 92 (12), 4686-4695.

 

QL Ying et al. The ground state of embryonic stem cell self-renewal. Nature, 2008, 453, 519-523. [online]

 

 

Chemical Name: 2-(2-Chloro-4-iodo-phenylamino)-N-cyclopropylmethoxy-3,4-difluoro-benzamide

 

PD 184352 - CI-1040 | MEK 1 inhibitor | Axon Medchem | Axon 1368 | PD184352 - CI1040

Axon Ligands TM - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.

axonmedchem.com © 2012

 

Axon Ligands In This Field:

 

AZD 6244 | MEK inhibitor

GSK 1120212 | MEK inhibitor

PD 98059 | MEK inhibitor

PD 184352 | MEK inhibitor

PD 0325901 | MEK inhibitor

SL 327 | MEK inhibitor

 

BIRB 796 | p38 MAPK inhibitor

PD 169316 | p38 MAPK inhibitor

SB 203580 | p38 MAPK inhibitor

SB 202190 | p38 MAPK inhibitor

SCIO 469 | p38 MAPK inhibitor

SD 169 | p38α MAPK inhibitor

 

BIX 02189 | MEK5/ERK5 inhibitor

FR 180204 | ERK inhibitor

XMD8-92 | BMK1 inhibitor

 

Click Here To See Featured Cell Signaling and Oncology Ligands from Axon Ligands Collection

 

Prime Source Information:

PD184352/CI-1040 from Axon Medchem has been procured by many labs as drug standard for generating reliable & reproducible biological data, evidenced by many recent publications.